CollPlant
-
CollPlant, a regenerative and aesthetics medicine company, today announced the appointment of Hugh Evans to its Board of Directors, increasing the board to six independent members. U.S.-based Mr. Evans brings extensive board, 3D…
-
CollPlant, a regenerative and aesthetic medicine company, released positive financial results for the full year ended December 31, 2020. The company also issued forward guidance for 2021. The update follows…
-
CollPlant Biotechnologies released a letter from its Chief Executive Officer, Yehiel Tal, to its shareholders. The letter summarizes a strong year for the company and its shareholders, which has benefitted from…
